Pruritus Therapeutics Market

Pruritus Therapeutics Market | 2019 - 2026 | Size & Growth

Pruritus Therapeutics Market Analysis – By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors & Others), By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria & Others), By Geography ( North America (United States & Canada), Europe (United Kingdom, Italy, Germany, Spain, France & Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Australia, New Zealand, Rest of APAC), Latin America (Brazil, Mexico, Argentina & Rest of Latin America), Middle East & Africa) – Global Industry Size, Growth, share, Value, Demand & Forecast Report | 2019 - 2026

ID : 72996037 |
Published : Oct-2019 |
Region : Global |
Pages : 90 |
Publisher : Polaris Market Research

Pruritus Therapeutics Market Size, Growth Rate & Forecast (2019 - 2026)

Pruritus Therapeutics Market size is anticipated to reach over USD 17,275.12 Million by the end of 2026, according to a new research report by Research Cosmos.

Pruritus, also known as itch disorder can be triggered by several ailments ranging from dermatological disorders such as mycoses, atopic dermatitis, chickenpox, and contact dermatitis, Pruritus is interrelated with the dermatologic and systemic causes. A typical itching generally forms the diagnosis of a key dermatologic syndrome. Several skin diseases that are related to pruritus include renal pruritus, hematologic pruritus, cholestatic pruritus, idiopathic generalized pruritus, pruritus related to malignancy and endocrine pruritus.

The rising incidence of dermatological disorder influencing the occurrence of pruritus and subsequently, the rising demand for proper diagnostics as well as therapeutics to treat such medical conditions is anticipated to bolster the market growth. The rise in inorganic development strategies is recognized as one of the key factors in boosting the growth of the pruritus therapeutics market. In addition, the key players of the pruritus therapeutics market are progressively adopting growth strategies such as partnerships, regional acquirements, and mergers and acquisitions. Such growth strategies are anticipated to result in technological advancement owing to enhancement in the product portfolio and mutual collaboration in R&D further boosting the market growth.

Pruritus Therapeutics Market is Segmented into following types as per Research Report :

Pruritus Therapeutics Market – By Product

Corticosteroids

Antihistamines

Local Anesthetics

Counterirritants

Immunosuppressant

Calcineurin Inhibitors

Others

Pruritus Therapeutics Market – By Disease Type

Atopic Dermatitis

Allergic Contact Dermatitis

Urticaria

Others

Pruritus Therapeutics Market – By Region

North America

Europe

Asia pacific

Latin America

Middle East and Africa

Rest of the World

Regionally, North America was estimated to dominate the global pruritus therapeutics market. Dominance is majorly due to the presence of favorable government initiatives and the introduction of new products.

Moreover, the rising incidence of target disorders and the existence of pruritus inducing climatic disorders in this region are anticipated to boost the market growth during the forecast period. However, Asia Pacific is anticipated to dominate the global Pruritus Therapeutics Market.

The growing incidence of atopic dermatitis and urticarial and presence of unmet healthcare organization needs are the factors attributed to the growth of the market in the Asia Pacific.

Top Prominent Key Players mentioned in Global Pruritus Therapeutics Market Research Report are:

Allergan Inc.

Amgen Inc.

Astellas Pharma Inc.

CARA Therapeutics

Novartis AG

Teva Pharmaceutical Industries Ltd

10 Plus More Key Players

Table of Contents

1. Overview and Scope

1.1. Research goal & scope

1.2. Research assumptions

1.3. Research Methodology

1.3.1. Primary data sources

1.3.2. Secondary data sources

1.4. Key take-aways

1.5. Stakeholders

2. Executive Summary

2.1. Market Definition

2.2. Market Segmentation

3. Pruritus Therapeutics Market Insights

3.1. Pruritus Therapeutics– Industry snapshot

3.2. Pruritus Therapeutics- Ecosystem analysis

3.3. Pruritus Therapeutics Market dynamics

3.3.1. Pruritus Therapeutics– Market Forces

3.3.1.1. Pruritus Therapeutics Market driver analysis

3.3.1.2. Pruritus Therapeutics Market restraint/challenges analysis

3.3.1.3. Pruritus Therapeutics Market opportunity analysis

3.4. Industry analysis - Porter's five force

3.4.1. Bargaining power of supplier

3.4.2. Bargaining power of buyer

3.4.3. Threat of substitute

3.4.4. Threat of new entrant

3.4.5. Degree of competition

3.5. Pruritus Therapeutics Market PEST analysis, 2017

3.5.1. Pruritus Therapeutics Industry trends

3.5.2. Competitive Ranking Analysis

4. Pruritus Therapeutics Market Size and Forecast by Product

4.1. Key findings

4.2. Corticosteroids

4.2.1. Global market estimates and forecasts, 2017 – 2026

4.3. Antihistamines

4.3.1. Global market estimates and forecasts, 2017 – 2026

4.4. Local Anesthetics

4.4.1. Global market estimates and forecasts, 2017 – 2026

4.5. Counterirritants

4.5.1. Global market estimates and forecasts, 2017 – 2026

4.6. Immunosuppressant

4.6.1. Global market estimates and forecasts, 2017 – 2026

4.7. Calcineurin Inhibitors

4.7.1. Global market estimates and forecasts, 2017 – 2026

4.8. Others

4.8.1. Global market estimates and forecasts, 2017 – 2026

5. Pruritus Therapeutics Market Size and Forecast by Disease Type

5.1. Key findings

5.2. Atopic Dermatitis

5.2.1. Global market estimates and forecasts, 2017 - 2026

5.3. Allergic Contact Dermatitis

5.3.1. Global market estimates and forecasts, 2017 - 2026

5.4. Urticaria

5.4.1. Global market estimates and forecasts, 2017 - 2026

5.5. Others

5.5.1. Global market estimates and forecasts, 2017 - 2026

6. Pruritus Therapeutics Market Size and Forecast by Regions

6.1. Key findings

6.2. North America

6.2.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.2.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.2.3. U.S.

6.2.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.2.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.2.4. Canada

6.2.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.2.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.3. Europe

6.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.3.3. Germany

6.3.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.3.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.3.4. UK

6.3.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.3.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.3.5. France

6.3.5.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.3.5.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.3.6. Italy

6.3.6.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.3.6.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.4. Asia Pacific

6.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.4.3. China

6.4.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.4.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.4.4. India

6.4.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.4.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.4.5. Japan

6.4.5.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.4.5.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.4.6. Australia

6.4.6.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.4.6.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.5. Latin America

6.5.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.5.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.5.3. Brazil

6.5.3.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.5.3.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.5.4. Mexico

6.5.4.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.5.4.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

6.6. Middle East & Africa

6.6.1. Pruritus Therapeutics Market by Product, 2017 - 2026

6.6.2. Pruritus Therapeutics Market by Disease Type, 2017 - 2026

7. Company Profiles

7.1. Allergan Inc.

7.1.1. Overview

7.1.2. Financials

7.1.3. Product Benchmarking

7.1.4. Recent Developments

7.2. Amgen Inc.

7.2.1. Overview

7.2.2. Financials

7.2.3. Product Benchmarking

7.2.4. Recent Developments

7.3. Astellas Pharma Inc.

7.3.1. Overview

7.3.2. Financials

7.3.3. Product Benchmarking

7.3.4. Recent Developments

7.4. CARA Therapeutics

7.4.1. Overview

7.4.2. Financials

7.4.3. Product Benchmarking

7.4.4. Recent Developments

7.5. Novartis AG

7.5.1. Overview

7.5.2. Financials

7.5.3. Product Benchmarking

7.5.4. Recent Developments

7.6. Teva Pharmaceutical Industries Ltd.

7.6.1. Overview

7.6.2. Financials

7.6.3. Product Benchmarking

7.6.4. Recent Developments

Purchase this Market Research Report

Single User License - 5500
SINGLE USER LICENSE
Single user license allows one specific user to access the product.
Team License - 7500
TEAM LICENSE
Team License allows multiple users to access the product.
Corporate License - 9500
CORPORATE LICENSE
Corporate License allows users across the whole organization to access the product.

Add to cart Buy Now

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?

View FAQS

Pruritus Therapeutics Market Size, Growth Rate & Forecast (2019 - 2026)

Related Reports

Coronary Artery Disease Therapeutics Market Research Report

Infectious Disease Therapeutics Market Status and Outlook to

Purchase this Market Research Report

Industry Newsletter